Most Popular Stories
- Forum: IT won't help much until practices shift operations
- Maryland hospitals' care judged by state analytical tool
- HIPAA 5010 transition big challenge for hospitals
- Trend: Arizona providers de-installing electronic medical records
- SPOTLIGHT: Indiana brags about HIT accomplishments
- White House reform director served on boards w/questionable behavior
Poll
Featured Jobs
-
Area Center Compliance & Ethics Leader
AstraZeneca - Wilmington, DE -
Director of Med/Surg Job for Maryland
StaffPointe, LLC - near D.C., MD -
Dir of Nursing/LTC Job for Kentucky
StaffPointe, LLC - Lexington, KY -
Dir/Quality Initiatives Job for Texas
StaffPointe, LLC - Fort Worth, TX -
RN/Director of Compliance Job in Oklahoma
StaffPointe, LLC - Tulsa, OK
Events
Paid Research Reports
- Pricing and Reimbursement in Key Asia Pacific Markets
- Delivery Mechanisms for Large Molecule Drugs: Successes and failures of leading technologies and key drivers for market success
- The Cardiovascular Market Outlook to 2013: Competitive landscape, global market analysis and pipeline analysis
- Intellectual Property and Outsourcing in China: Minimizing risk whilst maximizing return on investment
- Health Care Equipment & Supplies: Global Industry Guide
- 2009 Trends to Watch: Healthcare Technology
Hot Topics >> Reader's Corners | Health plan CEO paychecks | Twitter | iPhone healthcare apps
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 46,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
- Medicare
- health plans
- Centers for Medicare and Medicaid Services (CMS)
- Insurance
- Food and Drug Administration (FDA)
- Electronic Medical Records (EMRs)
- Department of Health and Human Services (HHS)
- Medicaid
- American Medical Association (AMA)
- healthcare system
- prescription drugs
- UnitedHealth Group
- pharmaceutical companies
CA bill would let pharmacies sell patient prescription data
A new California bill working its way through the state Senate would allow pharmacies there to sell patient prescription information to third-party marketing firms working for pharmaceutical companies. The legislation, which is expected to pass the Senate, would let pharmas send mailings directly to patients. The bill's supporters say that the intent of the mailings would be to remind patients to take their meds and order refills.
It's worth noting, by the way, that this goes well beyond the so-called "data mining" that already routinely takes place in most states (other than those that have banned the practice). In those cases, pharmaceutical industry intermediaries like IMS Health collect data on physician prescribing patterns. Pharmas buy the data from IMS and its peers, then go out to the practices to sell doctors using the knowledge they've gained of that doctor's prescribing patterns. This, on the other hand, is a direct-to-consumer communications initiative.
Opponents like the Consumer Federation of California contend that the bill would allow the pharmas to intrude into consumers' private lives. The California Medical Association also opposes the measure, contending that it could harm patient safety and physician-patient relationships, particularly in the case of patients with sensitive medical issues like mental illnesses. Supporters, however, say they've addressed this issue by allowing people to opt out of the mailings when they go to pick up their prescriptions.
To learn more about the bill:
- read this San Francisco Chronicle piece
Related Articles:
WA attempts prescription data mining ban
Fight continues over state limits on prescription data mining
Data providers challenge prescription-privacy laws
Related Stories
- Trend: States try to counter pharma drug marketing
- MA leaders seek crackdown on medication abuse
- Senators plan bill countering pharma detailing tactics
- Louisiana MDs win legal battle over patient record disclosure
- Studies show problems with four big-name drugs
- Did pharma ask the FDA for off-label rule change?
- MD leaked Avandia results to GSK
- WA attempts prescription data mining ban
- Biotechs eager for FDA approval of biogeneric drugs
- FTC: Pharmas cut 14 deals to delay generic sales in '07
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2009 FierceMarkets, Inc. All rights reserved. |
![]() |






Click here to get the FierceHealthcare email newsletter for FREE!
Be the first to comment